GLIOTRAIN Represented at the Inaugural Cancer Research UK Brain Tumour Conference Held in London, May 2018
GLIOTRAIN was represented at the inaugural CRUK Brain Tumour Conference, which was held in London from 1–3rd May 2018.
Welcome to GLIOTRAIN
Exploiting GLIOblastoma intractability to address European research TRAINing needs in translational brain tumour research, cancer systems medicine and integrative multi-omics
A MARIE SKŁODOWSKA-CURIE ACTIONS (MSCA) Innovative Training Network (ITN)
About GLIOTRAIN
An estimated 240,000 cases of brain and nervous system tumours are diagnosed every year, worldwide and Glioblastoma (GBM) is the most frequent and aggressive brain tumour. New treatment options and effective precision medicine therapies are urgently required. GLIOTRAIN is a multi-sectoral industry-academia collaboration, funded by the European Union's Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie ITN initiative, that will work to identify novel strategies to treat GBM as well as investigating resistance mechanisms in this devastating disease.
Latest news
GLIOTRAIN Represented at the Patient Voice in Cancer Event Held at UCD on 11th April 2018
GLIOTRAIN was represented by Dr Alice O'Farrell at The Patient Voice in Cancer Research IV event held at UCD.
Joint Public Outreach Event organised by GLIOTRAIN and Brain Tumour Ireland
On Friday 9th March Prof Annette Byrne, GLIOTRAIN Coordinator and Mr Stephen McNally, Consultant Neurosurgeon at Beaumont Hospital took part in a joint event hosted by Brain Tumour Ireland and Royal College of Surgeons in Ireland.
The Team
